Cassava Sciences Statistics
Share Statistics
Cassava Sciences has 48.11M shares outstanding. The number of shares has increased by 13.76% in one year.
| Shares Outstanding | 48.11M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 41.80M |
| Failed to Deliver (FTD) Shares | 7.50K |
| FTD / Avg. Volume | 0.15% |
Short Selling Information
The latest short interest is 18.57M, so 38.6% of the outstanding shares have been sold short.
| Short Interest | 18.57M |
| Short % of Shares Out | 38.6% |
| Short % of Float | 44.46% |
| Short Ratio (days to cover) | 11.61 |
Valuation Ratios
The PE ratio is -9.71 and the forward PE ratio is -15.1.
| PE Ratio | -9.71 |
| Forward PE | -15.1 |
| PS Ratio | 0 |
| Forward PS | 2.7 |
| PB Ratio | 6.87 |
| P/FCF Ratio | -11.45 |
| PEG Ratio | n/a |
Enterprise Valuation
Cassava Sciences Inc. has an Enterprise Value (EV) of -.
| EV / Earnings | null |
| EV / Sales | null |
| EV / EBITDA | null |
| EV / EBIT | null |
| EV / FCF | null |
Financial Position
The company has a current ratio of 9.13, with a Debt / Equity ratio of 0.
| Current Ratio | 9.13 |
| Quick Ratio | 9.13 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.71% and return on capital (ROIC) is -77.08%.
| Return on Equity (ROE) | -0.71% |
| Return on Assets (ROA) | -0.64% |
| Return on Capital (ROIC) | -77.08% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -3.35M |
| Employee Count | 29 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -90.61% in the last 52 weeks. The beta is -0.58, so Cassava Sciences 's price volatility has been lower than the market average.
| Beta | -0.58 |
| 52-Week Price Change | -90.61% |
| 50-Day Moving Average | 20.8 |
| 200-Day Moving Average | 21.66 |
| Relative Strength Index (RSI) | 23.19 |
| Average Volume (20 Days) | 5.09M |
Income Statement
In the last 12 months, Cassava Sciences had revenue of $0 and earned -$97.22M in profits. Earnings per share was $-2.32.
| Revenue | 0 |
| Gross Profit | -89.42M |
| Operating Income | -105.96M |
| Net Income | -97.22M |
| EBITDA | -95.69M |
| EBIT | - |
| Earnings Per Share (EPS) | -2.32 |
Balance Sheet
The company has $121.14M in cash and $0 in debt, giving a net cash position of $121.14M.
| Cash & Cash Equivalents | 121.14M |
| Total Debt | 0 |
| Net Cash | 121.14M |
| Retained Earnings | -380.77M |
| Total Assets | 223.75M |
| Working Capital | 145.51M |
Cash Flow
In the last 12 months, operating cash flow was -$82.03M and capital expenditures -$414.00K, giving a free cash flow of -$82.44M.
| Operating Cash Flow | -82.03M |
| Capital Expenditures | -414.00K |
| Free Cash Flow | -82.44M |
| FCF Per Share | -1.97 |
Margins
Gross margin is 0%, with operating and profit margins of 0% and 0%.
| Gross Margin | 0% |
| Operating Margin | 0% |
| Pretax Margin | 0% |
| Profit Margin | 0% |
| EBITDA Margin | n/a% |
| EBIT Margin | n/a% |
| FCF Margin | n/a% |
Dividends & Yields
SAVA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -83.75% |
| FCF Yield | -61.97% |
Analyst Forecast
The average price target for SAVA is $111.5, which is 3925.3% higher than the current price. The consensus rating is "Hold".
| Price Target | $111.5 |
| Price Target Difference | 3925.3% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
Stock Splits
The last stock split was on May 10, 2017. It was a backward split with a ratio of 1:7.
| Last Split Date | May 10, 2017 |
| Split Type | backward |
| Split Ratio | 1:7 |
Scores
| Altman Z-Score | -2.15 |
| Piotroski F-Score | 1 |